Rosa Nadal Selected Research

Androgen Receptors (Androgen Receptor)

4/2016	Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies.
1/2016	Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
8/2015	Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
9/2014	AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
2/2014	Enzalutamide for the treatment of prostate cancer: results and implications of the AFFIRM trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosa Nadal Research Topics

Disease

13	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 02/2014
11	Neoplasms (Cancer) 01/2023 - 05/2012
8	Carcinoma (Carcinomatosis) 01/2023 - 03/2014
5	Circulating Neoplastic Cells 08/2015 - 04/2013
5	Breast Neoplasms (Breast Cancer) 09/2014 - 07/2010
2	Disease Progression 01/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2014
1	Non-Muscle Invasive Bladder Neoplasms 01/2023
1	Carcinoma in Situ 01/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Adenocarcinoma 04/2014
1	Seizures (Absence Seizure) 02/2014
1	Osteoporosis 07/2010
1	Vitamin D Deficiency 07/2010
1	Avitaminosis (Vitamin Deficiency) 07/2010

Drug/Important Bio-Agent (IBA)

8	enzalutamideIBA 09/2020 - 02/2014
5	Docetaxel (Taxotere)FDA Link 09/2020 - 02/2014
5	abirateroneIBA 01/2017 - 09/2014
5	Androgen Receptors (Androgen Receptor)IBA 04/2016 - 02/2014
3	cabozantinibIBA 01/2022 - 01/2020
3	AndrogensIBA 09/2020 - 04/2014
3	Hormones (Hormone)IBA 01/2016 - 11/2015
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	NivolumabIBA 01/2022 - 11/2020
2	AntigensIBA 01/2016 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 08/2015 - 05/2012
2	Pharmaceutical PreparationsIBA 03/2014 - 02/2014
1	VaccinesIBA 01/2023
1	cyclopropapyrroloindoleIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2020
1	IpilimumabIBA 11/2020
1	PlatinumIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	RadiopharmaceuticalsIBA 11/2015
1	taxaneIBA 08/2015
1	Keratins (Keratin)IBA 09/2014
1	VimentinIBA 09/2014
1	Messenger RNA (mRNA)IBA 09/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2014
1	Everolimus FDA Link 03/2014
1	Phenobarbital (Luminal)FDA Link 05/2012
1	Vitamin D FDA LinkGeneric 07/2010
1	CalciumIBA 07/2010
1	hydroxide ionIBA 07/2010
1	Aromatase InhibitorsIBA 07/2010

Therapy/Procedure

14	Therapeutics 01/2023 - 05/2012
12	Castration 09/2020 - 02/2014
6	Drug Therapy (Chemotherapy) 09/2020 - 11/2013
2	Immunotherapy 01/2023 - 11/2015
1	Transurethral Resection of Bladder 01/2023
1	Urinary Diversion (Ileal Conduit) 01/2023